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Abstract
Apoptotic cells are thought to play an essential role in the
pathogenesis of systemic lupus erythematosus (SLE). We
hypothesise that delayed or altered clearance of apoptotic cells
after UV irradiation will lead to inflammation in the skin of SLE
patients. Fifteen SLE patients and 13 controls were irradiated
with two minimal erythemal doses (MEDs) of ultraviolet B light
(UVB). Subsequently, skin biopsies were analysed
(immuno)histologically, over 10 days, for numbers of apoptotic
cells, T cells, macrophages, and deposition of immunoglobulin
and complement. Additionally, to compare results with
cutaneous lesions of SLE patients, 20 biopsies of lupus
erythematosus (LE) skin lesions were analysed morphologically
for apoptotic cells and infiltrate. Clearance rate of apoptotic
cells after irradiation did not differ between patients and
controls. Influx of macrophages in dermal and epidermal layers
was significantly increased in patients compared with controls.
Five out of 15 patients developed a dermal infiltrate that was
associated with increased epidermal influx of T cells and
macrophages but not with numbers of apoptotic cells or
epidermal deposition of immunoglobulins. Macrophages were
ingesting multiple apoptotic bodies. Inflammatory lesions in
these patients were localised near accumulations of apoptotic
keratinocytes similar as was seen in the majority of LE skin
lesions. In vivo clearance rate of apoptotic cells is comparable
between SLE patients and controls. However, the presence of
inflammatory lesions in the vicinity of apoptotic cells, as
observed both in UVB-induced and in LE skin lesions in SLE
patients, suggests that these lesions result from an inflammatory
clearance of apoptotic cells.
Introduction
Systemic lupus erythematosus (SLE) is a systemic autoim-
mune disease characterised by the presence of autoantibod-
ies directed against nuclear and cytoplasmic antigens in
combination with a wide range of clinical manifestations. Pho-
tosensitivity is one of its manifestations, affecting 30% to 50%
of patients [1-3]. Most cutaneous lupus lesions can be trig-
gered by sunlight exposure. Sunlight exposure, especially
ultraviolet B light (UVB), can even induce systemic disease
activity. UVB is a potent inducer of apoptosis. During the last
decade, it has become clear that apoptotic cells play an impor-
tant role in autoimmunity, in particular SLE [4].
During the process of apoptosis, intracellular antigens are
expressed on the surface of the apoptotic cell and exposed to
the immune system [5]. In susceptible mice and rats, injection
of apoptotic cells results in loss of tolerance, autoantibody for-
mation, and even clinical disease [6,7]. In humans, the role of
apoptotic cells in the induction of autoimmunity is not yet clear.
In established SLE, decreased clearance of apoptotic cells by
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macrophages [8-10], increased levels of circulating apoptotic
cells [11,12], and presence of apoptotic cells in lupus skin
lesions [13] have been reported. Whether accumulation of
apoptotic cells induces autoimmunity and/or drives the
autoimmune disease after tolerance has been broken, has not
yet been elucidated.
Apoptotic epidermal cells can be recognised in the skin by
their pyknotic nuclei and eosinophilic cytoplasm in sections
stained with haematoxylin eosin (H&E) and are known as sun-
burn cells (SBCs) [14]. SBCs can be detected as early as 8
hours after UVB exposure, with maximal numbers being
present at 24 to 48 hours [15]. We previously showed that
induction of SBCs in the skin of patients with SLE does not dif-
fer from that in healthy controls after a single standardised
dose of UVB [16].
Apoptotic cells are formed in several tissues as part of normal
tissue homeostasis or are induced by influences from the envi-
ronment. Under physiological circumstances, phagocytes can
rapidly clear apoptotic cells without causing any tissue dam-
age. Upon ingestion of apoptotic cells, phagocytes release
anti-inflammatory cytokines such as transforming growth fac-
tor-β. In patients with SLE, however, autoantibodies may rec-
ognise autoantigens exposed on the surface of apoptotic cells
[5]. Binding of autoantibodies to apoptotic cells can result in
Fcγ-receptor (FcγR)-mediated clearance of apoptotic cells. It
is conceivable that this leads to inflammation given that ligation
of FcγR induces the release of pro-inflammatory cytokines
[17,18]. In this study, we analysed whether apoptotic keratino-
cytes in patients with SLE, as induced by a single dose of
UVB, are cleared with delay and/or in an inflammatory way that
results in the development of inflammatory skin lesions.
Materials and methods
Patients and controls
Patients eligible for the study fulfilled at least four ACR (Amer-
ican College of Rheumatology) criteria for SLE [19] and had
inactive disease, defined as SLEDAI (SLE Disease Activity
Index) of not greater than 4. Patients with active skin disease,
and those patients and controls whose buttock skin had been
exposed to sunlight or other sources of UVB in the past 6
months, were excluded from the study. The local ethics com-
mittee of the University Medical Center Groningen (The Neth-
erlands) approved the study, and all patients and controls gave
written informed consent according to the Declaration of Hel-
sinki. Fifteen patients (age 48.7 ± 12.3 years [mean ± stand-
ard deviation (SD)]; four males, 11 females) were included.
Skin types were determined based on the Fitzpatrick skin typ-
ing chart [20]. Skin type distribution (apart from two type 5 or
higher scores in non-Caucasian patients) was similar in
patients (three type 2, 10 type 3, one type 5, and one type 6)
and controls (four type 2 and nine type 3). Table 1 shows
patient characteristics and immunosuppressive medication
used at the time of the study. Autoantibodies to double-
stranded DNA were measured by Farr assay, and antibodies
to SSA/Ro, SSB/La, nRNP, and Sm were assessed by coun-
ter immuno-electrophoresis. Anti-cardiolipin antibodies, immu-
n o g l o b u l i n  ( I g )  G  o r  I g M ,  w e r e  t e s t e d  b y  e n z y m e - l i n k e d
immunosorbent assay. Minimal erythemal dose (MED) was
determined as described below. Thirteen healthy volunteers
(age 33.8 ± 15.8 years [mean ± SD]; five males, eight
females) were included as controls. Additionally, to compare
results with established cutaneous lesions of patients with
SLE, 20 biopsies of LE skin lesions were retrieved from the
files of the Department of Pathology (Table 2).
Irradiation protocol
UVB irradiation was performed using the Waldman 800 'sky'
lights with TL-12 lamps (Philips, Eindhoven, The Netherlands)
at a distance of 15 cm from the buttock skin. A Diffey grid [21]
was used to irradiate the skin with 10 different doses (0.026
to 0.200 J/cm2) during one exposure. After 24 hours, MED
was determined by two independent observers, with more
than 90% agreement. MED is defined as the lowest UVB dose
at which erythema can be detected in the skin. In case of dis-
agreement between observers, the mean of the two values
was used. The reproducibility of MED assessment was deter-
mined by a second irradiation in 10 subjects, five healthy con-
trols and five patients. Inter-test variability ranged from 0% to
22% (median 3%). After assessment of MED, subjects were
irradiated with two MEDs of UVB on four small areas (1 × 2.5
cm/area) on the other buttock. After 1, 3, and 10 days, 4 mm
skin biopsies were taken from the area of skin irradiated with
two MEDs. As a control, a biopsy was taken after 1 day from
non-irradiated skin. The distance between the biopsies was at
least 2 cm to avoid the influence of wound healing on the reac-
tion to UVB. Biopsies were split, one half fixed in formaldehyde
and the other half snap-frozen in liquid nitrogen.
Chemicals and antibodies
Diaminobenzidine (DAB) solution contained 25 mg DAB and
50 mg imidazol in 50 ml phosphate-buffered saline (PBS) and
was filtrated before use. AEC (3-amino-9-ethylcarbazole).
(Sigma-Aldrich, St. Louis, MO, USA) stock solution was
diluted 100× in acetate buffer (0.05 M, pH 5.0). To both stain-
ing solutions, H202 was added just before incubation of the
sections, resulting in a concentration of 0.1% H202. For hae-
matoxylin staining, Mayer's haemalum solution (Merck, Darm-
stadt, Germany) was used.
Rabbit antibodies to cleaved caspase-3 (no. 9661S) were
purchased from Cell Signaling Technology, Inc. (Danvers, MA,
USA). Primary fluorescein isothiocyanate (FITC)-labeled goat
F(ab)2 antibodies directed against human IgM, IgA, and IgG
were purchased from Protos Immunoresearch (Burlingame,
CA, USA). Primary mouse antibodies directed against CD68
(clone PGGM 1), CD3-FITC-labeled (clone F7.2.38), C3c-
FITC-labeled (clone F201), and C1q-FITC labeled (F0254),
and all secondary antibodies (that is, goat anti-rabbit IgG-Available online http://arthritis-research.com/content/8/6/R156
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horseradish peroxidase [HRP], rabbit anti-goat IgG-HRP, and
rabbit anti-mouse IgG-HRP) were obtained from DakoCyto-
mation (Glostrup, Denmark).
Immunohistochemistry
Skin sections (4 µm) on APES (3-amino-propyltriethoxysi-
lane)-coated glass slides were used for all experiments. Sec-
tions were deparaffinised by subsequent incubations in xylene
(10 minutes), 100% ethanol (5 minutes), and 96% ethanol (2
minutes), twice, followed by ethanol 70% (2 minutes) and dis-
tilled water. H&E staining was performed according to stand-
ard protocol using the linear stainer from medite
Medizintechnik GmbH (Burgdorf, Germany). Antigen retrieval
was performed by boiling in 1 mM EDTA (ethylenediamine-
tetraacetic acid) pH 8.0 (cleaved-caspase-3 staining), 10 mM
citrate pH 6.0 (CD68 staining), or 10 mM Tris, 1 mM EDTA pH
9.0 (CD3 staining). After washing in PBS, endogenous perox-
idase was blocked by incubation in 0.37% H202 in PBS for 30
minutes. Slides were incubated with various antibodies
(diluted 1:75 for anti-cleaved caspase-3 and 1:50 for CD68
and CD3, in 1% bovine serum albumin [BSA]/PBS) for 1 to 2
hours at room temperature. Subsequently, slides were
washed in PBS (three times) and incubated for 30 minutes at
room temperature with either goat anti-rabbit IgG-HRP (for
cleaved caspase-3 staining) or rabbit anti-mouse IgG-HRP
(for CD68 and CD3 staining) (1:50 in 1% BSA/PBS) and then
washed again (three times) in PBS followed by incubation with
rabbit anti-goat IgG-HRP or goat anti-rabbit IgG-HRP, respec-
tively, for another 30 minutes at room temperature. After wash-
ing in PBS (three times), slides were incubated in DAB
solution for 15 to 20 minutes and subsequently washed with
distilled water (five times). Slides were then counterstained
with haematoxylin for 1 minute, washed in distilled water (five
times), dehydrated in 96% ethanol and subsequently in 100%
ethanol, and then mounted. Using Leica QWin software (Leica
Microsystems, Cambridge, UK), morphometry was performed
on entire skin tissue sections stained with antibodies against
CD68 or CD3. Epidermal and papillary dermal layers (approx-
imately 150 µm of dermal layer directly localised beneath the
Table 1
Characteristics of patients included in the UVB irradiation study: cumulative ACR criteria, autoantibody specificities, medication, 
and MED at the time of the study
Patient characteristics
Infiltrate No. Gender Age A C R Prednisone Hydroxychloroquine  Azathio  prine  Autoantibody  MED 
( y e a r s ) 123456789 1 0 1 1 ( m g / d a y ) ( m g / d a y ) ( m g / d a y ) s p e c i f i c i t i e s ( J / c m 2)




- 2 F 6 4-+------+ + + 1 0 - 1 0 0d s D N A / S S A /
phosL
0.280
- 3 F 33 + - - - + + + - + + + 5 400 100 dsDNA 0.075
- 4 F 5 3+-+-+++-+++ 5 - 7 5 d s D N A0 . 0 7 0
- 5 F 3 6----++--+++ - 6 0 0 - d s D N A /
nRNP
0.100
+ 6 M 7 6 - - - -+++++++ 7 . 5 - - d s D N A / S S A 0 . 0 9 0
- 7 M 3 8+---------- 5 - 7 5 d s D N A / S S A /
SSB
0.050
+ 8 F 64 - - - - + + - - + + + - - 150 dsDNA 0.180
- 9 F 5 0----+-+-+++ 1 0 - 1 0 0 d s D N A / S S A 0 . 1 8 0
- 10 M 67 - - + - - - + - + - + 3.5 - 25 SSA/phosL 0.070
- 11 F 42 - - + + + - - - - + + 5 400 75 dsDNA/SSA/
nRNP/Sm
0.130
+ 1 2M 4 9--+-+ +----+ 5 - - n R N P0 . 1 0 0
- 13 F 57 - + - - + - + - + + + 5 - 100 dsDNA/Sm 0.085
+ 1 4 F 5 3--+-+----+ + - 2 0 0 - d s D N A /
nRNP
0.075
- 15 F 47 + + + - - - + - + - + 5 - 150 SSA/phosL 0.075
ACR criteria numbered according to Bombardier et al. [19]: 1, malar (or 'butterfly') rash; 2, discoid rash; 3, sensitivity to light, or photosensitivity; 4, 
oral ulcers; 5, arthritis; 6, serositis; 7, kidney disorder; 8, neurologic disorder; 9, blood abnormalities; 10, positive antiphospholipid antibody test; 11, 
immunologic disorder, including lupus anticoagulant, positive anti-double-stranded DNA, false-positive syphilis test, or positive anti-Smith test (such 
as anticardiolipin). + and - indicate cumulative presence or absence, respectively, of a particular criterion. In the leftmost column, + indicates 
patients with infiltrates. ACR, American College of Rheumatology; F, female, M, male; MED, minimal erythemal dose; UVB, ultraviolet B light.Arthritis Research & Therapy    Vol 8 No 6    Reefman et al.
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epidermis) were assessed separately by manually drawing a
line around these layers under ×100 magnification.
Scoring procedure for apoptotic cells
Using Olympus Soft Pro software (Tokyo, Japan), the surface
area of the epidermis was determined by manually drawing a
line around this area and calculating the total surface (mm2).
Subsequently, numbers of SBCs and nuclear dust were
scored in three sequential H&E-stained sections. Nuclear dust
was defined as one whole pyknotic nucleus or a group of
pyknotic nuclear fragments (as indicated in Figure 1f by black
and white arrows, respectively). Numbers of SBCs or extent of
nuclear dust per square millimeter was determined by dividing
the counted numbers by the epidermal surface area and cal-
culating the mean value of the three sections. Cleaved cas-
pase-3-positive cells were scored accordingly.
Figure 1
Clearance of apoptotic cells from irradiated skin in patients with systemic lupus erythematosus (SLE) compared with controls Clearance of apoptotic cells from irradiated skin in patients with systemic lupus erythematosus (SLE) compared with controls. Representative 
images of skin sections stained for cleaved caspase-3 (a) 1 day, (b) 3 days, and (c) 10 days after irradiation with two minimal erythemal doses of 
ultraviolet B light (UVB). Arrowheads indicate cleaved caspase-3-positive cells. Magnifications, ×200. (d) Graph showing numbers of sunburn cells 
(SBCs) per square millimeter in patients (n = 15) and controls (n = 13). (e) Number of cleaved caspase-3-positive keratinocytes per square millim-
eter. ● , patients (P); ❍ , controls (C). Median is indicated by a horizontal line. (f) A representative hematoxylin eosin (H&E)-stained section after irra-
diation with UVB, showing SBCs (white arrowheads) and nuclear dust (black arrows indicate one intact pyknotic nucleus, white arrow indicates 
pyknotic fragmented nucleus).Available online http://arthritis-research.com/content/8/6/R156
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Scoring procedure for infiltrating cells and inflammatory 
lesions
Infiltrating cells in the dermis were scored semi-quantitatively
and by morphometry. H&E sections were semi-quantitatively
scored for the presence of infiltrating cells using a score from
0 to 5. In short, vessels in the papillary dermis were scored
blindly for the presence of perivascular infiltrating cells, in
three consecutive sections: no infiltrating cells (0), not more
than two infiltrating cells (1), not more than one perivascular
layer of infiltrating cells (2), two or three layers of infiltrating
cells (3), more than three layers of infiltrating cells (4), and
more than three layers of infiltrating cells in combination with
clear progression outside the perivascular region (5). The final
score was determined by averaging the mean vessel score of
three consecutive sections. Morphometry was performed on
the dermal layer of CD3- and CD68-stained sections. Infil-
trates in patients were considered present when the semi-
quantitative scores of dermal influx of infiltrating cells in H&E-
stained sections and the morphometric scores of either CD3-
or CD68-stained OK sections were increased (> mean + two
SDs of controls) in biopsies taken on at least two different
days, after UVB irradiation.
Table 2
Characteristics of patients included in the LE skin biopsies: cumulative ACR criteria, autoantibody specificities, and medication
Patient characteristics
SBC/co-loc No. Gender Age A C R Prednisone Hydroxychloroquine Azathioprine Autoantibody
(Years) 1 2 3 4 5 6 7 8 9 10 11 (mg/day) (mg/day) (mg/day) specificities
+/+ 1 F 45 - - - - - + + - - + + - 75 SSA/SSB/
dsDNA
+ / + 2 F 5 1+-+--+--+-+ 5 - 1 0 0 S S A / S S B
+/+ 3 F 70 - + - - - - - - + + + 10 200 25 Sm/SSA/
nRNP
- / - 4 M4 7-+ +-----+ + - - - S S A / S S B
- / - 5 F 4 5++-++- - -+++ - 5 - S m / n R N P /
CL
+/- 6 F 50 + + - + + - - - + + + 12.5 600 - Sm/nRNP/
CL
+ / + 7 F 4 9++-++- - -+++ 1 0 6 0 0 - S m / n R N P /
CL
+ / - 8 F 3 9+-+++----++ 6 0 - - d s D N A
+/+ 9 F 41 + - - - + + - - - + + 2.5 - 75 SSA/SSB/
dsDNA
+/+ 10 F 45 - + - - + + + - + + + 5 400 - dsDNA
+/+ 11 F 46 - + - - + + + - + + + 5 400 - dsDNA
+ / - 1 2F3 8-+--+----+ + - - - d s D N A
- / - 1 3F7 5----+---+ + + - - - d s D N A / C L
+/- 14 F 33 + - - - + - - - + + + - - - SSA/Sm/
nRNP/
dsDNA
+ / + 1 5F5 8-+ +-----+ + + - - - S S A / d s D N A
+ / - 1 6F3 8-+ +-----+ + + - - - S S A / d s D N A
-/- 17 F 49 - + + - - - + - + - + - 800 - dsDNA/CL
+ / + 1 8 F 4 9-+-+++--+++ 7 . 5 - - d s D N A
+/+ 19 M 35 - + + - - - - - + + - - - SSA/dsDNA
+/- 20 F 26 + - + - - - - - + + + - - - nRNP/Sm/
dsDNA
ACR criteria numbered according to Bombardier et al. [19]: 1, malar (or 'butterfly') rash; 2, discoid rash; 3, sensitivity to light, or photosensitivity; 4, 
oral ulcers; 5, arthritis; 6, serositis; 7, kidney disorder; 8, neurologic disorder; 9, blood abnormalities; 10, positive antiphospholipid antibody test; 11, 
immunologic disorder, including lupus anticoagulant, positive anti-double-stranded DNA, false-positive syphilis test, or positive anti-Smith test (such 
as anticardiolipin). + and - indicate cumulative presence or absence, respectively, of a particular criterion. In the leftmost column, +/- indicates 
biopsies containing SBCs but no apparent co-localisation, +/+ indicates biopsies containing co-localisation of inflammatory lesions and SBCs, and 
- indicates biopsies without SBCs. ACR, American College of Rheumatology; co-loc, co-localisation; F, female, LE, lupus erythematosus; M, male; 
SBC, sunburn cell; UVB, ultraviolet B light.Arthritis Research & Therapy    Vol 8 No 6    Reefman et al.
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Additionally, H&E-stained sections from biopsies taken before
and after irradiation and biopsies of LE skin lesions were
assessed for the presence of inflammatory lesions and co-
localisation with SBCs. Inflammatory lesions were defined as
the presence of category 5 (see above) vessel(s) in the der-
mis, with inflammatory cell infiltration of the epidermal layer
coinciding with marked local hydropic degeneration of the
basal layer of the epidermis (Figure 2h). Co-localisation was
regarded as present when inflammatory lesions coincided with
the presence of two or more SBCs in the epidermal layer lying
over the infiltrate. Scoring was performed by two independent
observers not informed about the clinical findings.
Deposition of Igs and complement
Sequential frozen sections were used for direct immunofluo-
rescent staining of IgM, IgG, IgA, C3c, and C1q, using stand-
ard procedures. In brief, sections were washed with PBS and
subsequently incubated with the various FITC-labeled specific
antibodies at the dilutions indicated. After incubation, sections
were washed in PBS again, and nuclei were stained using bis-
benzimide (SERVA Electrophoresis GmbH, Heidelberg, Ger-
many) and mounted. Sections were scored by two
independent observers for staining at the dermal-epidermal
junction (lupus-band) and in the epidermal layer.
Statistics
Differences between groups were determined using the
Mann-Whitney test. The χ2 test was used to analyse categori-
cal variables. Comparison of multiple groups was performed
by one-way analysis of variance (Kruskal-Wallis). Correlations
between numbers of apoptotic cells detected by H&E staining
and numbers detected by cleaved caspase-3 staining and
between SBCs and pyknotic nuclear debris were analysed
using the nonparametric (Spearman) correlation test. To ana-
lyse differences in the level of correlation between patients
and controls, slopes of linear regression lines were compared
(GraphPad Software 3.02; GraphPad Software, Inc., San
Diego, CA, USA).
Results
Clearance of apoptotic cells from SLE skin after a single 
dose of UVB
To investigate apoptotic cell clearance, apoptotic cells were
quantified in H&E staining by their altered morphology as
SBCs and by the detection of cleaved caspase-3 as a specific
apoptotic marker. Significant aspecific staining was observed
in basal and spinotic epidermal layers and, to a lesser extent,
in the dermis of non-irradiated skin using the TUNEL (terminal
deoxynucleotidyl transferase-mediated in situ nick-end
labeling) detection method (data not shown). However, results
from the two detection methods indicated above did highly
correlate, r  = 0.91, p < 0.0001. One day after irradiation,
apoptotic cells were localised mainly in the stratum spinosum
(Figure 1a). After 3 days, approximately 70% of SBCs were
localised in the stratum granulosum (Figure 1b), and after 10
days, nearly all apoptotic cells were removed from the skin,
partially by shedding (Figure 1c). No SBCs or cleaved cas-
pase-3-positive cells were detected in unexposed skin (Figure
1d,e). After 1 day, SBCs could be detected in patients (88.8
± 51.8 SBCs per mm2 [mean ± SD]) and controls (101.9 ±
68.6 SBCs per mm2, p = 0.71). At day 3, the number of apop-
totic cells was increased three- to nine-fold in patients (358.2
± 138.8 SBCs per mm2) and controls (321.8 ± 127.3 SBCs
per mm2, p = 0.42). Ten days after irradiation, patients (11.0
± 11.6 SBCs per mm2) and controls (6.0 ± 5.6 SBCs per
mm2) had decreased, but similar, numbers of apoptotic cells,
which resided in the epidermis (p = 0.41).
Nuclear dust, defined as one whole pyknotic nucleus or a
group of pyknotic nuclear fragments (Figure 1f), could be
detected after irradiation. The extent of nuclear dust strongly
correlated with numbers of SBCs (r = 0.91, p < 0.0001).
Clearance rate of nuclear dust was comparable with clearance
of apoptotic cells and did not differ between patients with SLE
and controls (data not shown).
Development of infiltrates and inflammatory lesions in 
patients with SLE after irradiation and in LE skin lesions
To study the inflammatory response induced by a single dose
of UVB irradiation, skin biopsies were taken after 1, 3, and 10
days and stained with H&E. In general, in skin from control
subjects, some influx of inflammatory cells was seen after 1
day, decreasing over time with only low influx remaining after
10 days compared with non-irradiated skin. Influx was local-
ised mainly around the dermal blood vessels (Figure 2a–c,g).
In five out of 15 patients, influx of cells was increased, espe-
cially after 3 days, and persisted after 10 days (Figure 2d–g).
In two of these patients, the infiltrate progressed toward the
basal layer of the epidermis, which was damaged as indicated
by the presence of marked hydropic degeneration. Based on
pre-defined criteria, these were considered inflammatory
lesions (Materials and methods). Inflammatory lesions were
localised only in the vicinity of apoptotic keratinocytes (Figure
2h).
To determine whether the inflammatory lesions seen in the
vicinity of SBCs after irradiation might also be present in
established LE lesions, biopsies of 20 LE skin lesions were
assessed for co-localisation of infiltrate and SBCs (Table 2). In
16 out of 20 LE biopsies, SBCs could be detected, and in 10
of these biopsies, co-localisation of inflammatory lesions and
local accumulation of SBCs was seen (Figure 3). The latter
group of patients could not be distinguished from the other
patients by any of the characteristics depicted in Tables 1 and
2.
Characterisation and quantification of infiltrating cells 
and deposition of Igs and complement
To characterise and quantify the infiltrating cells, sections
were stained using a T-cell (CD3) and monocyte/macrophageAvailable online http://arthritis-research.com/content/8/6/R156
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(CD68) marker. Subsequently, staining in the papillary dermis
and epidermis was quantified by morphometry. In the dermis
of non-irradiated skin, low numbers of T cells (0.25% ± 0.20%
in patients versus 0.27% ± 0.17% in controls) and macro-
phages (0.69% ± 0.45% in patients versus 0.70% ± 0.33%
in controls) were present. Influx of T cells and macrophages
increased in all subjects 1 day after irradiation, declined
slowly, and was only slightly increased after 10 days com-
pared with non-irradiated skin (Figure 4a,b). Macrophages
were increased in the skin of patients with SLE after 1 day as
Figure 2
Development of infiltrates and inflammatory lesions in the vicinity of sunburn cells (SBCs) in patients with systemic lupus erythematosus (SLE) Development of infiltrates and inflammatory lesions in the vicinity of sunburn cells (SBCs) in patients with systemic lupus erythematosus (SLE). Hae-
matoxylin eosin (H&E)-stained paraffin sections before and after irradiation with two minimal erythemal doses of ultraviolet B light (UVB). (a-c) Biop-
sies from a representative control, non-irradiated (a) and 1 (b) and 3 (c) days after irradiation. (d-f) Biopsies from a representative patient with 
increased influx of cells, non-irradiated (d) and 1 (e) and 3 (f) days after irradiation. Magnifications, ×100. (g) Graph showing semi-quantitative anal-
ysis of infiltrate in H&E sections before and up to 10 days after irradiation. Dotted lines indicate mean + two standard deviations of controls. ● , 
patients (P); ❍ , controls (C). No significant differences were present between patients and controls on any time point. (h) Inflammatory lesion in a 
patient with SLE in the vicinity of SBCs 3 days after irradiation. Inflammatory lesions were defined as the presence of category 5 (see Materials and 
methods) vessel(s) in the dermis, with inflammatory cell infiltration of the epidermal layer coinciding with marked local hydropic degeneration of the 
basal layer of the epidermis. Insert shows magnification of area with accumulating SBCs. Magnification, ×100. White arrowheads indicate SBCs, 
and black arrowheads indicate hydropic degeneration.Arthritis Research & Therapy    Vol 8 No 6    Reefman et al.
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compared with controls (1.19% ± 0.55% and 0.66% ±
0.35%, respectively, p = 0.02). T-cell influx was not signifi-
cantly different at any time point between patients and
controls. Neutrophils were accidentally (one to five cells per 4
mm section) detected in H&E staining in both controls and
patients (data not shown). Five patients developed infiltrates of
inflammatory cells detected by semi-quantitative analysis in
H&E-stained sections and by morphometric analysis in CD3-
or CD68-stained sections on at least two different days after
irradiation. This group of patients could not be distinguished
from the other patients by any of the patient characteristics
listed in Tables 1 and 2. In the patients who developed infil-
trates, levels of T-cell and macrophage influx were in the same
range as seen in 20 skin biopsies from patients with cutane-
ous LE lesions (Figure 4). This group of patients with cutane-
ous LE lesions could not be distinguished from the patients
who got UVB irradiation to the skin by any of the patient char-
acteristics listed in Tables 1 and 2.
Influx of T cells and macrophages was not limited to the dermal
layer of the skin. T cells and, especially, macrophages were
detected in the epidermis as well. In the epidermis of non-irra-
diated skin, almost no T cells (0.010% ± 0.011% in patients,
0.028% ± 0.023% in controls) (Figure 4c) or macrophages
(0.026% ± 0.047% in patients, 0.0005% ± 0.0008% in con-
trols) (Figure 4e) could be detected. However, 3 days after
irradiation, a substantial number of macrophages were
observed in the epidermal compartment. Influx into the epider-
mis was higher in patients (0.038% ± 0.074% for CD3, p =
0.02, and 0.26 ± 0.31 for CD68, p = 0.04) compared with
controls (0.0023% ± 0.0057% for CD3 and 0.061% ±
0.046% for CD68). Furthermore, epidermal influx was higher
in patients with infiltrates compared with patients without
these infiltrates and controls (p = 0.0009 for CD3-positive T
cells and p = 0.009 for CD68-positive macrophages) (Figure
4d,f).
Deposition of Igs and complement factors was studied to
assess their potential involvement in the inflammatory
response. Most intense staining of Igs and complement in the
epidermal layer was seen near local accumulations of
epidermal apoptotic cells. However, depositions were not
restricted to patients and could also be detected in all healthy
controls (data not shown).
Rate of clearance of apoptotic cells in patients with 
infiltrates
Numbers of apoptotic cells were compared between patients
with and without infiltrates to evaluate whether differences in
clearance rate of apoptotic cells might have been responsible
for the development of infiltrates. Patients with infiltrates in the
skin did not have increased numbers of apoptotic cells at any
Figure 3
Co-localisation of apoptotic keratinocytes and infiltrate in lupus erythematosus (LE) skin lesions Co-localisation of apoptotic keratinocytes and infiltrate in lupus erythematosus (LE) skin lesions. Sections of two representative LE skin lesions 
showing an area of local accumulation of apoptotic keratinocytes and local infiltration of inflammatory cells and hydropic degeneration of the epider-
mis. Arrowheads indicate apoptotic keratinocytes. Magnifications, ×40 (left panels) and ×200 (right panels).Available online http://arthritis-research.com/content/8/6/R156
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time point compared with patients without infiltrates and con-
trols (Figure 5a). Also, extent of nuclear dust did not differ at
any time point between patients with infiltrates and the remain-
ing patients without these infiltrates and controls (data not
shown).
Phagocytosis of apoptotic keratinocytes by 
macrophages in the epidermis
Macrophages in the epidermis were often localised in the
vicinity of apoptotic cells. Only in two patients with infiltrates,
a large proportion of the epidermal macrophages contained
multiple large vacuoles (Figure 5b). The morphology of these
vacuoles indicated ingestion of apoptotic cells. This was con-
firmed by counterstaining with H&E which showed that the
apoptotic bodies ingested by macrophages had an eosi-
nophilic stained cytoplasm (Figure 5c).
Discussion
In the present study, we demonstrated that the rate of clear-
ance of apoptotic cells after a single standardised dose of
UVB is not decreased in the skin of patients with SLE. How-
ever, we showed that in a subset of patients with SLE, UVB
irradiation results in the development of infiltrates and inflam-
matory lesions in the vicinity of apoptotic cells. Furthermore,
co-localisation of inflammatory lesions and apoptotic cells was
frequently seen in LE skin lesions, suggesting that inflamma-
tion after a single dose of UVB might represent early LE skin
lesions in which apoptotic cells play an inducing role. The infil-
trate that developed after irradiation consisted mainly of T cells
Figure 4
Infiltration of T cells and macrophages into the papillary dermis and epidermis Infiltration of T cells and macrophages into the papillary dermis and epidermis. (a) Percentage of CD3 staining in the dermis before and after irradia-
tion in 15 patients with systemic lupus erythematosus (SLE) and 12 controls and in 20 lupus erythematosus (LE) biopsies quantified by morphome-
try. (b) Percentage of CD68 staining in the dermis before and after irradiation in 15 patients with SLE and 12 controls and in 20 LE biopsies 
quantified by morphometry. (c) Percentage of CD3 staining in the epidermis before and after irradiation comparing patients with infiltrates (n = 5), 
patients without infiltrates (n = 10), and controls (n = 13) and in 20 LE biopsies. (d) Percentage of CD68 staining in the epidermis before and after 
irradiation comparing patients with infiltrates (n = 5), patients without infiltrates (n = 10), and controls (n = 13) and in 20 LE biopsies. Median value 
is indicated by a horizontal line. ■ , patients with infiltrates (IP); ● , patients without infiltrates (P); ❍ , controls (C). *p < 0.05, **p < 0.01, ***p ≤ 0.001. 
UVB, ultraviolet B light.Arthritis Research & Therapy    Vol 8 No 6    Reefman et al.
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and macrophages and was localised in the dermis and epider-
mis. In some patients with infiltrates, epidermal macrophages
were phagocytosing multiple apoptotic cell bodies.
The clearance rate of apoptotic cells or nuclear debris did not
differ between patients with SLE and controls. Also, the clear-
ance rate of apoptotic cells in patients with infiltrates was not
different from that of patients without these infiltrates and con-
trols. These data contrast with a recent paper by Kuhn et al.
[22] showing that apoptotic cell clearance after UV irradiation
was defective in the skin of patients with non-systemic cutane-
ous LE. Differences in methods used to detect apoptotic cells
might, at least in part, explain these discrepancies. Kuhn et al.
used two nick-labeling techniques to detect apoptosis. As dis-
cussed in a recent commentary [23], detection of DNA nicks
after UVB irradiation is not a reliable measure of apoptosis
[24-26]. We used other methods for detection of apoptotic
cells, namely by morphology in H&E-stained sections and by
Figure 5
Presence of apoptotic cells and phagocytosis by macrophages comparing controls and patients with or without infiltrates Presence of apoptotic cells and phagocytosis by macrophages comparing controls and patients with or without infiltrates. (a) Numbers of sunburn 
cells (SBCs) in patients with infiltrates, patients without infiltrates, and controls before and up to 10 days after irradiation. ■ , patients with infiltrates 
(IP); ● , patients without infiltrates (P); ❍ , controls (C). Extensive phagocytosis of apoptotic keratinocytes by macrophages in the epidermis of 
patients with infiltrates. (b) Representative biopsy showing CD68 staining combined with haematoxylin staining using diaminobenzidine (DAB) for 
visualisation of CD68-positive cells. Magnification, ×400. Two macrophages that contain multiple phagocytic vacuoles (black arrows) are shown. 
One vacuole clearly contains an apoptotic cell (checkered arrow). (c) Representative biopsy showing CD68 staining using DAB for visualisation, 
combined with haematoxylin eosin staining. Magnification, ×400. White arrow indicates macrophages not involved in phagocytosis, and checkered 
arrows indicate eosinophilic particles that are being ingested by macrophages. UVB, ultraviolet B light.Available online http://arthritis-research.com/content/8/6/R156
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specific staining for the cleaved form of caspase-3. Detection
of SBCs by H&E staining has been used extensively for many
years and detects apoptotic cells at a relatively late stage in
the apoptotic process [14,27]. Cleaved caspase-3 is an early
marker for apoptosis; its activity precedes all the morphologi-
cal changes that are initiated [28]. Both methods correlated
well.
In vitro, several reports have described decreased uptake of
apoptotic cells in SLE [8,29]. We recently showed that mac-
rophages of patients with SLE do not have intrinsic defects in
the clearing of apoptotic cells. However, decreased levels of
complement such as C1q and C4, during active disease in
particular, may lead to decreased phagocytosis of apoptotic
cells [10]. Also, experiments in lupus-prone mouse strains
suggest that the capacity of macrophages to internalise apop-
totic cells is normal when mice are not in a state of active dis-
ease [30,31]. Our data provide in vivo evidence that the
apoptotic cell clearance rate in patients with inactive SLE is
not disturbed in the skin after a single UVB exposure.
Clearance of apoptotic cells by phagocytes is usually an anti-
inflammatory event. We demonstrated that T cells and mainly
macrophages infiltrate into the epidermal layers of the skin.
This influx was almost restricted to patients and occurred
significantly more frequently in patients with infiltrates in the
dermal layer. Epidermal macrophages were often seen in the
vicinity of apoptotic cells and sporadically showed single
ingested apoptotic bodies. Macrophages in the epidermis of
two patients with infiltrates were phagocytosing multiple
apoptotic keratinocytes. To our knowledge, this phenomenon
has not been described in the skin before. These data suggest
that, in controls, the major part of apoptotic cells are cleared
by shedding and, possibly, phagocytosis by keratinocytes
[32], whereas only low numbers of macrophages seem to be
involved in the clearance of apoptotic cells from the skin. The
association between formation of infiltrates and participation
of macrophages in apoptotic cell clearance suggests a pro-
inflammatory role of the macrophages in these patients.
We hypothesise that the development of infiltrates as seen in
patients with SLE could be the result of inflammatory clear-
ance of apoptotic cells. Autoantibodies, especially directed
against SSA/Ro, have been shown to bind to apoptotic
keratinocytes. Other reports have shown that binding of anti-
phospholipid antibodies to apoptotic cells results in increased
production of the pro-inflammatory cytokine tumour necrosis
factor-α [33]. Furthermore, Meller et al. [34] reported that UV
light-induced injury leads to apoptosis, necrosis, and cytokine/
chemokine production that results in an amplification cycle
leading to cutaneous LE lesions. However, they failed to deter-
mine which factor specifically induces inflammation in LE
lesions. Binding of autoantibodies to apoptotic keratinocytes
in the skin and subsequent pro-inflammatory clearance by
macrophages could be involved in induction of infiltrates in our
study. No association was found, however, between any par-
ticular autoantibody specificity and the occurrence of infil-
trates, although this could be due to the limited group size.
This hypothesis, however, is supported by a very recent article
by Clancy et al. [35] showing that maternal autoantibodies
may bind apoptotic cardiomyocytes and promote inflammation
thereby contributing to the pathogenesis of congenital heart
block.
It can be argued that our study has several other limitations as
well. First of all, these studies were conducted in only a limited
number of subjects and caution should be taken extrapolating
these results to the whole SLE population. Second, although
we used the MED to correct for differences in UV sensitivity,
inter-individual variation in skin types might have influenced the
results. Furthermore, given that erythema can be seen as an
early inflammatory response mediated largely by prostagland-
ins produced in the skin, any influence of immunosuppressive
medication used cannot be excluded [36]. Such an effect,
however, seems unlikely. Because topical administration of
corticosteroids can influence the MED response [37], patients
using topical corticosteroids at the time of the study were
excluded. Systemic administration of corticosteroids up to 80
mg daily was reported not to decrease erythema [38]. Conse-
quently, corticosteroids that were used by our patients at sub-
stantially lower doses (Tables 1 and 2) have in all likelihood not
influenced our results. Third, several reports have suggested
that multiple UVB exposures induce macroscopic LE-like
lesions [39,40]. Wolska et al. [41] have shown that single
exposure also can result in macroscopic lesions. We deliber-
ately chose a single-exposure approach because this method
has several advantages compared with the multiple-exposure
approach. Most importantly, single exposure enables the
analysis of stimulus and effect (that is, apoptosis induction,
apoptotic cell clearance, and induction of inflammation) with-
out interference of processes induced by repeated exposures.
Infiltrates were most apparent 3 and 10 days after a single
standardised dose of UVB. Although erythema was still visible
after 3 days, no clear macroscopic lesions could be detected
at that time, probably due to the small size of the irradiated
areas. The irradiated areas were intentionally kept small
because of the potential hazard of activating systemic disease
by irradiating large skin areas in patients with SLE.
Conclusion
From our data, we conclude that UVB irradiation of the skin of
patients with SLE can induce infiltrates and inflammatory
lesions. Although in vivo clearance of apoptotic cells after
UVB irradiation in patients with SLE was normal, the develop-
ment of lesions in the vicinity of apoptotic cells and their asso-
ciation with increased phagocytic activity of macrophages
suggest that an altered, inflammatory clearance of apoptotic
cells might be important in the development of lupus skin
lesions.Arthritis Research & Therapy    Vol 8 No 6    Reefman et al.
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